Who is sponsoring NCT05842577?

NCT05842577 is sponsored by IRCCS San Raffaele Roma.

What drugs are being tested in NCT05842577?

Interventions in NCT05842577: VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy), At-home conventional rehabilitation.

What condition does NCT05842577 study?

NCT05842577 studies Parkinson Disease.

Is NCT05842577 still recruiting?

NCT05842577 is currently completed. Last updated 28 June 2023.

Last reviewed 2023-06-28 · How we verify

NCT05842577: REPORT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RCT on Telerehabilitation Efficacy in Parkinson's Disease

Completed NA Last updated 28 June 2023

What this trial tests

NA trial testing VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy) in Parkinson Disease in 94 participants. Completed in 31 December 2021.

Timeline

1 July 2018

Primary endpoint
31 December 2020

31 December 2021

Quick facts

Lead sponsor	IRCCS San Raffaele Roma
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	94
Start date	1 July 2018
Primary completion	31 December 2020
Estimated completion	31 December 2021
Sites	6 locations across Italy

Drugs / interventions tested

VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy)
At-home conventional rehabilitation

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

IRCCS San Raffaele Roma — full company profile →

Who can join

Adults 18 to 80, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The implementation of regular prolonged, and effective rehabilitation in people with Parkinson's disease is essential for ensuring a good quality of life. However, the continuity of rehabilitation care may find barriers related to economic, geographic, and social issues. In these scenarios, telerehabilitation could be a possible solution to guarantee the continuity of care. This trial aims to investigate the efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in people with Parkinson's disease, compared to at-home conventional rehabilitation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson's disease: a multicenter randomized controlled trial.
Goffredo M, Baglio F, DE Icco R, Proietti S, et al · · 2023 · cited 28× · PMID 37847247 · DOI 10.23736/s1973-9087.23.07954-6
Efficacy and feasibility of virtual reality-based cognitive tele-rehabilitation in Parkinson's disease: A pilot randomized controlled trial on patients and caregivers.
Maggio MG, Rizzo A, Benenati A, Giambò Mauro F, et al · · 2025 · cited 2× · PMID 41018508 · DOI 10.1177/20552076251376534

Verify or expand the search:

Other trials of VRRS Tablet (Khymeia s.r.l., Noventa Padovana, Italy)

Trials testing the same drug.

NCT05773885 — Telerehabilitation in People With Parkinson's Disease · NA · recruiting

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other IRCCS San Raffaele Roma trials

Trials by the same sponsor.

NCT07431671 — Feeding Disorders in Children · NA · recruiting
NCT07097103 — Parkinson's Research In Metagenomic Early Stage Biomarkers · NA · not yet recruiting
NCT06868953 — Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study · not yet recruiting
NCT06839482 — Robotic Rehabilitation of the Upper Limb in Subacute Stroke · NA · recruiting
NCT06915584 — Drug Management in Heart Failure · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05842577 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele Roma
Last refreshed: 28 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05842577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing